APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

IsraelRecruitingPHASE2

Conditions

Pancreatic Acinar Cell Carcinoma · Pancreatic Adenosquamous Carcinoma · Pancreatic Squamous Cell Carcinoma · Resectable Pancreatic Acinar Cell Carcinoma · Resectable Pancreatic Adenocarcinoma · Resectable Pancreatic Adenosquamous Carcinoma · Resectable Pancreatic Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States

  • Anchorage Radiation Therapy Center, Anchorage, Alaska, United States

  • Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States

  • Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States

  • Alaska Women's Cancer Care, Anchorage, Alaska, United States

  • Anchorage Oncology Centre, Anchorage, Alaska, United States

  • Katmai Oncology Group, Anchorage, Alaska, United States

  • Providence Alaska Medical Center, Anchorage, Alaska, United States

  • Fairbanks Memorial Hospital, Fairbanks, Alaska, United States

  • Kingman Regional Medical Center, Kingman, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Cancer Center at Saint Joseph's, Phoenix, Arizona, United States

  • Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States

  • CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · Emily.Carvell@bmhcc.org · 870-936-7066
    Contact: Principal Investigator (Stephen W. Behrman)
  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande, California, United States

  • PCR Oncology, Arroyo Grande, California, United States

  • Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Ari D. Baron)
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States

  • Memorial Medical Center, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Ari D. Baron)
  • Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California, United States

  • Saint Joseph Hospital - Orange, Orange, California, United States

    Contact: Study coordinator (Site Public Contact) · 714-734-6220
    Contact: Principal Investigator (Timothy E. Byun)
  • Sutter Roseville Medical Center, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Ari D. Baron)
  • Sutter Medical Center Sacramento, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Ari D. Baron)
  • California Pacific Medical Center-Pacific Campus, San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Ari D. Baron)
  • Pacific Central Coast Health Center-San Luis Obispo, San Luis Obispo, California, United States

  • Mills Health Center, San Mateo, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Ari D. Baron)
  • Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Ari D. Baron)
  • Mission Hope Medical Oncology - Santa Maria, Santa Maria, California, United States

  • Providence Medical Foundation - Santa Rosa, Santa Rosa, California, United States

    Contact: Study coordinator (Site Public Contact) · 707-521-3830
    Contact: Principal Investigator (Alison K. Conlin)
  • Sutter Pacific Medical Foundation, Santa Rosa, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org · 415-209-2683
    Contact: Principal Investigator (Ari D. Baron)
  • Providence Santa Rosa Memorial Hospital, Santa Rosa, California, United States

  • Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Ari D. Baron)
  • Northbay Cancer Center, Vacaville, California, United States

    Contact: Study coordinator (Site Public Contact) · 707-624-8007
    Contact: Principal Investigator (Brian G. Vikstrom)
  • Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States

  • Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States

  • AdventHealth Porter, Denver, Colorado, United States

  • CommonSpirit Cancer Center Mercy, Durango, Colorado, United States

  • Mercy Medical Center, Durango, Colorado, United States

  • Saint Anthony Hospital, Lakewood, Colorado, United States

  • AdventHealth Littleton, Littleton, Colorado, United States

  • Longmont United Hospital, Longmont, Colorado, United States

  • Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States

  • AdventHealth Parker, Parker, Colorado, United States

  • Saint Mary Corwin Medical Center, Pueblo, Colorado, United States

  • Sibley Memorial Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · jquiver1@jhmi.edu · 202-243-2373
    Contact: Principal Investigator (Michael J. Pishvaian)
  • AdventHealth Altamonte, Altamonte Springs, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 407-303-2200
    Contact: Principal Investigator (Mohamedtaki A. Tejani)
  • AdventHealth Celebration, Celebration, Florida, United States

  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Nkiruka Ezenwajiaku)
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Nkiruka Ezenwajiaku)
  • AdventHealth Kissimmee, Kissimmee, Florida, United States

  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Nkiruka Ezenwajiaku)
  • UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Nkiruka Ezenwajiaku)
  • AdventHealth Medical Group Urology at Orlando, Orlando, Florida, United States

  • AdventHealth Orlando, Orlando, Florida, United States

    Contact: Study coordinator (Site Public Contact) · FH.Cancer.Research@flhosp.org · 407-303-2090
    Contact: Principal Investigator (Mohamedtaki A. Tejani)
  • AdventHealth East Orlando, Orlando, Florida, United States

  • UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Nkiruka Ezenwajiaku)
  • AdventHealth Winter Park, Winter Park, Florida, United States

  • Emory University Hospital Midtown, Atlanta, Georgia, United States

  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · i.webster@hawaiicancercare.com · 808-524-6115
    Contact: Principal Investigator (Jared D. Acoba)
  • Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-532-0315
    Contact: Principal Investigator (Jared D. Acoba)
  • Queen's Medical Center, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-545-8548
    Contact: Principal Investigator (Jared D. Acoba)
  • Straub Clinic and Hospital, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-522-4333
    Contact: Principal Investigator (Jared D. Acoba)
  • Queen's Cancer Center - Kuakini, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-531-8521
    Contact: Principal Investigator (Jared D. Acoba)
  • Hawaii Cancer Care - Westridge, ‘Aiea, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · info@hawaiicancercare.com · 808-539-2273
    Contact: Principal Investigator (Jared D. Acoba)
  • Pali Momi Medical Center, ‘Aiea, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-486-6000
    Contact: Principal Investigator (Jared D. Acoba)
  • The Queen's Medical Center - West Oahu, ‘Ewa Beach, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · rohta@queens.org
    Contact: Principal Investigator (Jared D. Acoba)
  • Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • OSF Saint Anthony's Health Center, Alton, Illinois, United States

  • Rush-Copley Medical Center, Aurora, Illinois, United States

  • Illinois CancerCare-Bloomington, Bloomington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Canton, Canton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Memorial Hospital of Carbondale, Carbondale, Illinois, United States

  • SIH Cancer Institute, Carterville, Illinois, United States

  • Illinois CancerCare-Carthage, Carthage, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Centralia Oncology Clinic, Centralia, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • University of Illinois, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-355-3046
    Contact: Principal Investigator (Shikha Jain)
  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Dixon, Dixon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 815-285-7800
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • Crossroads Cancer Center, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Elmhurst Memorial Hospital, Elmhurst, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Jrohde@emhc.org · 630-758-5460
    Contact: Principal Investigator (Hollis Walker)
  • Illinois CancerCare-Eureka, Eureka, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Galesburg, Galesburg, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States

  • Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Macomb, Macomb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • SSM Health Good Samaritan, Mount Vernon, Illinois, United States

  • Edward Hospital/Cancer Center, Naperville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 630-646-6075
    Contact: Principal Investigator (Hollis Walker)
  • UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Ardaman Shergill)
  • Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States

  • Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Pekin, Pekin, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Peoria, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Methodist Medical Center of Illinois, Peoria, Illinois, United States

  • Illinois CancerCare-Peru, Peru, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Valley Radiation Oncology, Peru, Illinois, United States

  • Edward Hospital/Cancer Center?Plainfield, Plainfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Cancerresearch@edward.org · 630-646-6075
    Contact: Principal Investigator (Hollis Walker)
  • Illinois CancerCare-Princeton, Princeton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 217-545-7929
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-444-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Memorial Hospital, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · pallante.beth@mhsil.com · 217-528-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Suparna Mantha)
  • The Carle Foundation Hospital, Urbana, Illinois, United States

  • Illinois CancerCare - Washington, Washington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Rush-Copley Healthcare Center, Yorkville, Illinois, United States

  • IU Health North Hospital, Carmel, Indiana, United States

  • Northwest Cancer Center - Crown Point, Crown Point, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@powershealth.org · 219-836-6879
    Contact: Principal Investigator (Suparna Mantha)
  • Northwest Oncology LLC, Dyer, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 219-924-8178
    Contact: Principal Investigator (Suparna Mantha)
  • Saint Mary Medical Center, Hobart, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@COMHS.org · 219-836-6875
    Contact: Principal Investigator (Suparna Mantha)
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States

  • The Community Hospital, Munster, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 219-836-3349
    Contact: Principal Investigator (Suparna Mantha)
  • Memorial Hospital of South Bend, South Bend, Indiana, United States

  • Mary Greeley Medical Center, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • McFarland Clinic - Ames, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · ksoder@mcfarlandclinic.com · 515-239-4734
    Contact: Principal Investigator (Joseph J. Merchant)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • McFarland Clinic - Boone, Boone, Iowa, United States

  • Saint Anthony Regional Hospital, Carroll, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · sbenson@iora.org · 515-689-7658
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Cancer Center-West Lakes, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Alegent Health Mercy Hospital, Council Bluffs, Iowa, United States

  • Heartland Oncology and Hematology LLP, Council Bluffs, Iowa, United States

  • Nebraska Cancer Specialists/Oncology Hematology West PC - MEJ, Council Bluffs, Iowa, United States

  • Greater Regional Medical Center, Creston, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Broadlawns Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-282-2200
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Medical Center - Des Moines, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Iowa Lutheran Hospital, Des Moines, Iowa, United States

  • McFarland Clinic - Trinity Cancer Center, Fort Dodge, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • UI Healthcare Mission Cancer and Blood - Fort Dodge, Fort Dodge, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · trials@missioncancer.com · 515-282-2921
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • McFarland Clinic - Jefferson, Jefferson, Iowa, United States

  • McFarland Clinic - Marshalltown, Marshalltown, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Methodist West Hospital, West Des Moines, Iowa, United States

  • Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • University of Kansas Clinical Research Center, Fairway, Kansas, United States

  • Central Care Cancer Center - Garden City, Garden City, Kansas, United States

  • Central Care Cancer Center - Great Bend, Great Bend, Kansas, United States

  • HaysMed, Hays, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · 785-623-5774
    Contact: Principal Investigator (Anup K. Kasi Loknath Kumar)
  • University of Kansas Cancer Center, Kansas City, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Anup K. Kasi Loknath Kumar)
  • Lawrence Memorial Hospital, Lawrence, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.Norris@LMH.ORG · 785-505-2800
    Contact: Principal Investigator (Anup K. Kasi Loknath Kumar)
  • The University of Kansas Cancer Center - Olathe, Olathe, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · OlatheCCResearch@kumc.edu · 913-588-1569
    Contact: Principal Investigator (Anup K. Kasi Loknath Kumar)
  • University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Anup K. Kasi Loknath Kumar)
  • University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Anup K. Kasi Loknath Kumar)
  • Freeman Physician Group of Pittsburg, Pittsburg, Kansas, United States

  • Mercy Hospital Pittsburg, Pittsburg, Kansas, United States

  • Salina Regional Health Center, Salina, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · mleepers@srhc.com · 785-452-7038
    Contact: Principal Investigator (Anup K. Kasi Loknath Kumar)
  • University of Kansas Health System Saint Francis Campus, Topeka, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · 785-295-8000
    Contact: Principal Investigator (Anup K. Kasi Loknath Kumar)
  • University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Anup K. Kasi Loknath Kumar)
  • Flaget Memorial Hospital, Bardstown, Kentucky, United States

  • Commonwealth Cancer Center-Corbin, Corbin, Kentucky, United States

  • Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky, United States

  • Saint Joseph Hospital East, Lexington, Kentucky, United States

  • Saint Joseph London, London, Kentucky, United States

  • Jewish Hospital, Louisville, Kentucky, United States

  • Saints Mary and Elizabeth Hospital, Louisville, Kentucky, United States

  • UofL Health Medical Center Northeast, Louisville, Kentucky, United States

  • Jewish Hospital Medical Center South, Shepherdsville, Kentucky, United States

  • Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana, United States

  • Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@marybird.com · 225-215-1353
    Contact: Principal Investigator (William T. Varnado)
  • Ochsner Hematology Oncology North Shore - Covington (West Region), Covington, Louisiana, United States

  • Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States

  • Hickman Cancer Center, Adrian, Michigan, United States

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CancerAnswerLine@med.umich.edu · 800-865-1125
    Contact: Principal Investigator (Thomas Enzler)
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health Medical Center - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health Medical Center - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Newland Medical Associates-Clarkston, Clarkston, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Corewell Health Dearborn Hospital, Dearborn, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (Dana Zakalik)
  • Henry Ford Health Saint John Hospital, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · Kkeenan1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford River District Hospital, East China Township, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Corewell Health Farmington Hills Hospital, Farmington Hills, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (Dana Zakalik)
  • Cancer Hematology Centers - Flint, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Genesee Hematology Oncology PC, Flint, Michigan, United States

  • Genesys Hurley Cancer Institute, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford Saint John Hospital - Academic, Grosse Pointe Woods, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford Saint John Hospital - Van Elslander, Grosse Pointe Woods, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford Saint John Hospital - Macomb Medical, Macomb, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, United States

  • Henry Ford Health Providence Novi Hospital, Novi, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kfife3@hfhs.org · 248-849-5332
    Contact: Principal Investigator (Susan E. Lyons)
  • Michigan Healthcare Professionals Pontiac, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · Emily.Crofts@trinity-health.org · 248-858-6215
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Newland Medical Associates-Pontiac, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (Dana Zakalik)
  • MyMichigan Medical Center Saginaw, Saginaw, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States

  • Henry Ford Health Providence Southfield Hospital, Southfield, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kfife3@hfhs.org · 248-849-5332
    Contact: Principal Investigator (Susan E. Lyons)
  • Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, United States

  • MyMichigan Medical Center Tawas, Tawas City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Corewell Health Beaumont Troy Hospital, Troy, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (Dana Zakalik)
  • Henry Ford Health Warren Hospital, Warren, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford Warren Hospital - GLCMS, Warren, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States

  • Huron Gastroenterology PC, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 218-333-5000
    Contact: Principal Investigator (Daniel Almquist)
  • Mercy Hospital, Coon Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Saint Luke's Hospital of Duluth, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · kdean@slhduluth.com · 218-249-7825
    Contact: Principal Investigator (Homam Alkaied)
  • Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Regions Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • United Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (David M. King)
  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Stephen W. Behrman)
  • Baptist Cancer Center-Grenada, Grenada, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Stephen W. Behrman)
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Stephen W. Behrman)
  • Baptist Memorial Hospital and Cancer Center-Oxford, Oxford, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Stephen W. Behrman)
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Stephen W. Behrman)
  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 888-446-3729
    Contact: Principal Investigator (Jay W. Carlson)
  • Central Care Cancer Center - Bolivar, Bolivar, Missouri, United States

  • Mercy Cancer Center - Cape Girardeau, Cape Girardeau, Missouri, United States

  • Saint Francis Medical Center, Cape Girardeau, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · sfmc@sfmc.net · 573-334-2230
    Contact: Principal Investigator (Bryan A. Faller)
  • Parkland Health Center - Farmington, Farmington, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • MU Health Care Goldschmidt Cancer Center, Jefferson City, Missouri, United States

  • Freeman Health System, Joplin, Missouri, United States

  • Mercy Hospital Joplin, Joplin, Missouri, United States

  • University Health Truman Medical Center, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 816-404-4375
    Contact: Principal Investigator (Anup K. Kasi Loknath Kumar)
  • Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · aroland@kccop.org · 913-948-5588
    Contact: Principal Investigator (Marc T. Roth)
  • University of Kansas Cancer Center - North, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Anup K. Kasi Loknath Kumar)
  • University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Anup K. Kasi Loknath Kumar)
  • Saint Luke's East - Lee's Summit, Lee's Summit, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · aroland@kccop.org · 913-948-5588
    Contact: Principal Investigator (Marc T. Roth)
  • University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri, United States

  • Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States

  • Phelps Health Delbert Day Cancer Institute, Rolla, Missouri, United States

  • Heartland Regional Medical Center, Saint Joseph, Missouri, United States

  • Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Mercy Hospital Springfield, Springfield, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 417-269-4520
    Contact: Principal Investigator (Jay W. Carlson)
  • CoxHealth South Hospital, Springfield, Missouri, United States

  • Mercy Infusion Center - Chippewa, St Louis, Missouri, United States

  • Mercy Hospital South, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · Danielle.Werle@mercy.net · 314-525-6042
    Contact: Principal Investigator (Jay W. Carlson)
  • Missouri Baptist Medical Center, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Mercy Hospital Saint Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-251-7066
    Contact: Principal Investigator (Jay W. Carlson)
  • Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • BJC Outpatient Center at Sunset Hills, Sunset Hills, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Mercy Hospital Washington, Washington, Missouri, United States

  • Community Hospital of Anaconda, Anaconda, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Billings Clinic Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · research@billingsclinic.org · 800-996-2663
    Contact: Principal Investigator (John M. Schallenkamp)
  • Bozeman Health Deaconess Hospital, Bozeman, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Benefis Sletten Cancer Institute, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States

  • Community Medical Center, Missoula, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Nebraska Cancer Specialists/Oncology Hematology West PC, Grand Island, Nebraska, United States

  • CHI Health Good Samaritan, Kearney, Nebraska, United States

  • Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States

  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-334-4773
    Contact: Principal Investigator (Mary Wells)
  • Nebraska Methodist Hospital, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-354-5144
    Contact: Principal Investigator (Mary Wells)
  • Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States

  • Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States

  • Alegent Health Lakeside Hospital, Omaha, Nebraska, United States

  • Creighton University Medical Center, Omaha, Nebraska, United States

  • Midlands Community Hospital, Papillion, Nebraska, United States

  • Carson Tahoe Regional Medical Center, Carson City, Nevada, United States

  • Cancer and Blood Specialists-Henderson, Henderson, Nevada, United States

  • Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, United States

  • Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, United States

  • Las Vegas Cancer Center-Henderson, Henderson, Nevada, United States

  • Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, United States

  • Las Vegas Urology - Green Valley, Henderson, Nevada, United States

  • Las Vegas Urology - Pebble, Henderson, Nevada, United States

  • Oncology Las Vegas - Henderson, Henderson, Nevada, United States

  • Urology Specialists of Nevada - Green Valley, Henderson, Nevada, United States

  • Las Vegas Urology - Pecos, Las Vegas, Nevada, United States

  • Desert West Surgery, Las Vegas, Nevada, United States

  • OptumCare Cancer Care at Charleston, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • University Medical Center of Southern Nevada, Las Vegas, Nevada, United States

  • Hope Cancer Care of Nevada, Las Vegas, Nevada, United States

  • Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, United States

  • Urology Specialists of Nevada - Central, Las Vegas, Nevada, United States

  • Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States

  • Las Vegas Prostate Cancer Center, Las Vegas, Nevada, United States

  • Las Vegas Urology - Sunset, Las Vegas, Nevada, United States

  • Urology Specialists of Nevada - Southwest, Las Vegas, Nevada, United States

  • Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, United States

  • Ann M Wierman MD LTD, Las Vegas, Nevada, United States

  • Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, United States

  • Las Vegas Urology - Cathedral Rock, Las Vegas, Nevada, United States

  • Las Vegas Urology - Smoke Ranch, Las Vegas, Nevada, United States

  • Oncology Las Vegas - Tenaya, Las Vegas, Nevada, United States

  • OptumCare Cancer Care at MountainView, Las Vegas, Nevada, United States

  • Urology Specialists of Nevada - Northwest, Las Vegas, Nevada, United States

  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, United States

  • Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada, United States

  • Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, United States

  • Summerlin Hospital Medical Center, Las Vegas, Nevada, United States

  • Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, United States

  • Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States

  • Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, United States

  • University Cancer Center, Las Vegas, Nevada, United States

  • OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, United States

  • Renown Regional Medical Center, Reno, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Saint Mary's Regional Medical Center, Reno, Nevada, United States

  • Radiation Oncology Associates, Reno, Nevada, United States

  • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, United States

    Contact: Study coordinator (Site Public Contact) · cancer.research.nurse@dartmouth.edu · 800-639-6918
    Contact: Principal Investigator (Kathryn C. Hourdequin)
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Fiyinfolu Balogun)
  • Cooper Hospital University Medical Center, Camden, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 856-325-6757
    Contact: Principal Investigator (Jamin C. Morrison)
  • Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Fiyinfolu Balogun)
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Fiyinfolu Balogun)
  • Holy Name Hospital, Teaneck, New Jersey, United States

  • MD Anderson Cancer Center at Cooper-Voorhees, Voorhees Township, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 856-325-6757
    Contact: Principal Investigator (Jamin C. Morrison)
  • University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · HSC-ClinicalTrialInfo@salud.unm.edu · 505-925-0348
    Contact: Principal Investigator (Erika Maestas)
  • Roswell Park Cancer Institute, Buffalo, New York, United States

    Contact: Study coordinator (Site Public Contact) · askroswell@roswellpark.org · 800-767-9355
    Contact: Principal Investigator (Kannan Thanikachalam)
  • Memorial Sloan Kettering Commack, Commack, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Fiyinfolu Balogun)
  • Northwell Health Cancer Institute at Huntington, Greenlawn, New York, United States

  • Memorial Sloan Kettering Westchester, Harrison, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Fiyinfolu Balogun)
  • Northwell Health/Center for Advanced Medicine, Lake Success, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Daniel A. King)
  • NYU Langone Hospital - Long Island, Mineola, New York, United States

    Contact: Study coordinator (Site Public Contact) · cancertrials@nyulangone.org · 212-263-4432
    Contact: Principal Investigator (Paul E. Oberstein)
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@nyulangone.org
    Contact: Principal Investigator (Paul E. Oberstein)
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Fiyinfolu Balogun)
  • Rochester General Hospital, Rochester, New York, United States

    Contact: Study coordinator (Site Public Contact) · tia.derosa@rochestergeneral.org · 585-922-3536
    Contact: Principal Investigator (Amy Bodrog)
  • Unity Park Ridge Campus, Rochester, New York, United States

    Contact: Study coordinator (Site Public Contact) · ctsucontact@westat.com · 888-823-5923
    Contact: Principal Investigator (Amy Bodrog)
  • Memorial Sloan Kettering Nassau, Uniondale, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Fiyinfolu Balogun)
  • Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 919-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 919-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 910-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Sanford Bismarck Medical Center, Bismarck, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Broadway Medical Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-234-6161
    Contact: Principal Investigator (Daniel Almquist)
  • Miami Valley Hospital South, Centerville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States

  • Bethesda North Hospital, Cincinnati, Ohio, United States

  • TriHealth Cancer Institute-Westside, Cincinnati, Ohio, United States

  • TriHealth Cancer Institute-Anderson, Cincinnati, Ohio, United States

  • Miami Valley Hospital, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Premier Blood and Cancer Center, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-276-8320
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Dayton Physician LLC - Englewood, Dayton, Ohio, United States

  • Miami Valley Hospital North, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Miami Valley Cancer Care and Infusion, Greenville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-569-7515
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Kettering Medical Center, Kettering, Ohio, United States

  • Mercy Health - Saint Anne Hospital, Toledo, Ohio, United States

  • Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States

  • Upper Valley Medical Center, Troy, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

  • Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · 405-752-3402
    Contact: Principal Investigator (Jay W. Carlson)
  • Saint Charles Health System, Bend, Oregon, United States

  • Clackamas Radiation Oncology Center, Clackamas, Oregon, United States

  • Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States

  • Bay Area Hospital, Coos Bay, Oregon, United States

  • Providence Newberg Medical Center, Newberg, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Willamette Falls Medical Center, Oregon City, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Oregon Health and Science University, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · trials@ohsu.edu · 503-494-1080
    Contact: Principal Investigator (Charles D. Lopez)
  • Saint Charles Health System-Redmond, Redmond, Oregon, United States

  • Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States

  • Main Line Health Center-Collegeville, Collegeville, Pennsylvania, United States

  • Main Line Health Center-Exton, Exton, Pennsylvania, United States

  • Riddle Memorial Hospital, Media, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · turzoe@mlhs.org · 484-476-2649
    Contact: Principal Investigator (Paul B. Gilman)
  • Paoli Memorial Hospital, Paoli, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · turzoe@mlhs.org · 484-476-2649
    Contact: Principal Investigator (Paul B. Gilman)
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · PMCancerResearch@pennmedicine.upenn.edu · 215-349-8245
    Contact: Principal Investigator (Kim A. Reiss Binder)
  • Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

  • Lankenau Medical Center, Wynnewood, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · turzoe@mlhs.org · 484-476-2649
    Contact: Principal Investigator (Paul B. Gilman)
  • Avera Cancer Institute-Aberdeen, Aberdeen, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · oncregulatory@avera.org · 605-622-8700
    Contact: Principal Investigator (Heidi A. McKean)
  • Avera Cancer Institute at Pierre, Pierre, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncRegulatory@avera.org · 605-322-3095
    Contact: Principal Investigator (Heidi A. McKean)
  • Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicTrialsSF@sanfordhealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Avera Cancer Institute, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncRegulatory@avera.org · 605-322-3095
    Contact: Principal Investigator (Heidi A. McKean)
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsSF@SanfordHealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Stephen W. Behrman)
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · BCCclintrials@bmhcc.org · 901-226-1366
    Contact: Principal Investigator (Stephen W. Behrman)
  • Saint Joseph Regional Cancer Center, Bryan, Texas, United States

  • Parkland Memorial Hospital, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-590-5582
    Contact: Principal Investigator (Timothy J. Brown)
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@utsouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Timothy J. Brown)
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Timothy J. Brown)
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Timothy J. Brown)
  • UT Southwestern Clinical Center at Richardson/Plano, Richardson, Texas, United States

    Contact: Study coordinator (Site Public Contact) · Suzanne.cole@utsouthwestern.edu · 972-669-7044
    Contact: Principal Investigator (Timothy J. Brown)
  • Farmington Health Center, Farmington, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Vaia Florou)
  • University of Utah Sugarhouse Health Center, Salt Lake City, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Vaia Florou)
  • Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Vaia Florou)
  • Dartmouth Cancer Center - North, Saint Johnsbury, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · cancer.research.nurse@hitchcock.org · 800-639-6918
    Contact: Principal Investigator (Kathryn C. Hourdequin)
  • Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States

  • MultiCare Auburn Medical Center, Auburn, Washington, United States

  • Overlake Medical Center, Bellevue, Washington, United States

  • PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States

  • Highline Medical Center-Main Campus, Burien, Washington, United States

  • Providence Regional Cancer System-Centralia, Centralia, Washington, United States

  • Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-2343
    Contact: Principal Investigator (Alison K. Conlin)
  • Saint Elizabeth Hospital, Enumclaw, Washington, United States

  • Providence Regional Cancer Partnership, Everett, Washington, United States

  • Saint Francis Hospital, Federal Way, Washington, United States

  • MultiCare Gig Harbor Medical Park, Gig Harbor, Washington, United States

  • Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-2343
    Contact: Principal Investigator (Alison K. Conlin)
  • Kadlec Clinic Hematology and Oncology, Kennewick, Washington, United States

    Contact: Study coordinator (Site Public Contact) · research@kadlecmed.org · 509-783-4637
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Regional Cancer System-Lacey, Lacey, Washington, United States

    Contact: Study coordinator (Site Public Contact) · deidre.dillon@providence.org · 360-412-8958
    Contact: Principal Investigator (Alison K. Conlin)
  • Saint Clare Hospital, Lakewood, Washington, United States

  • PeaceHealth Saint John Medical Center, Longview, Washington, United States

  • MultiCare Good Samaritan Hospital, Puyallup, Washington, United States

  • Valley Medical Center, Renton, Washington, United States

    Contact: Study coordinator (Site Public Contact) · research@valleymed.org · 425-228-3440
    Contact: Principal Investigator (John A. Ellerton)
  • Pacific Gynecology Specialists, Seattle, Washington, United States

  • Swedish Medical Center-Ballard Campus, Seattle, Washington, United States

  • Swedish Medical Center-Cherry Hill, Seattle, Washington, United States

  • Swedish Medical Center-First Hill, Seattle, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-2343
    Contact: Principal Investigator (Alison K. Conlin)
  • PeaceHealth United General Medical Center, Sedro-Woolley, Washington, United States

  • Providence Regional Cancer System-Shelton, Shelton, Washington, United States

  • Saint Michael Cancer Center, Silverdale, Washington, United States

  • MultiCare Deaconess Cancer and Blood Specialty Center - Downtown, Spokane, Washington, United States

  • MultiCare Deaconess Cancer and Blood Specialty Center - North, Spokane, Washington, United States

  • MultiCare Deaconess Cancer and Blood Specialty Center - Valley, Spokane Valley, Washington, United States

  • Franciscan Research Center-Northwest Medical Plaza, Tacoma, Washington, United States

  • MultiCare Tacoma General Hospital, Tacoma, Washington, United States

  • PeaceHealth Southwest Medical Center, Vancouver, Washington, United States

  • Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States

  • North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, United States

  • Providence Regional Cancer System-Yelm, Yelm, Washington, United States

  • United Hospital Center, Bridgeport, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Nour Daboul)
  • West Virginia University Healthcare, Morgantown, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Nour Daboul)
  • Camden Clark Medical Center, Parkersburg, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Nour Daboul)
  • ThedaCare Regional Cancer Center, Appleton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ResearchDept@thedacare.org · 920-364-3604
    Contact: Principal Investigator (Matthias Weiss)
  • Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Kareem H. Abdelhadi)
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Brian L. Burnette)
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Brian L. Burnette)
  • Mercyhealth Hospital and Cancer Center - Janesville, Janesville, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncologyclinicaltrials@mhemail.org · 608-756-6871
    Contact: Principal Investigator (Emily G. Robinson)
  • University of Wisconsin Carbone Cancer Center - Johnson Creek, Johnson Creek, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Monica A. Patel)
  • Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · cancerctr@gundersenhealth.org · 608-775-2385
    Contact: Principal Investigator (Kurt Oettel)
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Monica A. Patel)
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Monica A. Patel)
  • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Kareem H. Abdelhadi)
  • Marshfield Medical Center - Minocqua, Minocqua, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Kareem H. Abdelhadi)
  • ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · research.institute@phci.org
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7878
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Brian L. Burnette)
  • Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Kareem H. Abdelhadi)
  • Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Brian L. Burnette)
  • Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Kareem H. Abdelhadi)
  • Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Brian L. Burnette)
  • ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7632
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Chanda.miller@phci.org · 262-928-5539
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Marshfield Medical Center - Weston, Weston, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Kareem H. Abdelhadi)
  • Rambam Medical Center, Haifa, Israel

    Contact: Study coordinator (Site Public Contact) · y_rozen@rambam.health.gov.il · 972-4-8541737
    Contact: Principal Investigator (Irit Ben Aharon)
  • Pan American Center for Oncology Trials LLC - Dorado, Dorado, Puerto Rico

    Contact: Study coordinator (Site Public Contact) · info@panoncologytrials.com · 787-407-3333
    Contact: Principal Investigator (Marcia R. Cruz-Correa)
  • Pan American Center for Oncology Trials LLC, San Juan, Puerto Rico

    Contact: Study coordinator (Site Public Contact) · marcia.cruzcorrea@panoncologytrials.com · 787-407-3333
    Contact: Principal Investigator (Marcia R. Cruz-Correa)
Study leads
  • Kim A Reiss Binder

    Principal Investigator

    ECOG-ACRIN Cancer Research Group